2017

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2017, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

Noncommunicable diseases in people living with HIV: time for integrated care
van der Valk M, Reiss P
J Infect Dis. 2017 Dec 19;216(12):1481-1483. doi: 10.1093/infdis/jix525. Abstract

Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma
Shepherd L, Ryom L, Law M, Hatleberg CI, de Wit S, Monforte AD, Battegay M, Phillips A, Bonnet F, Reiss P, Pradier C, Grulich A, Sabin C, Lundgren J, Mocroft A.
J Natl Cancer Inst. 2017 Dec 18. doi: 10.1093/jnci/djx249. [Epub ahead of print] Abstract

Management of drug interactions with direct-acting antivirals in Dutch HIV/HCV co-infected patients: adequate but not perfect
Smolders EJ, Smit C, de Kanter C, Dofferhoff A, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM; ATHENA National HIV Observational Cohort.
HIV Med. 2017 Dec 1. doi: 10.1111/hiv.12570. [Epub ahead of print] Abstract

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
van Sighem A, Pharris A, Quinten C, Noori T, Amato-Gauci AJ,the ECDC HIV/AIDS Surveillance and Dublin Declaration Monitoring Networks. 
Euro Surveill. 2017;22(48):pii=17-00771. https://doi.org/10.2807/1560-7917.ES.2017.22.48.17-00771 Artikel

High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands
Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, Rijnders BJA, Brinkman K, Valk MV; NVHB-SHM hepatitis working group and the Netherlands ATHENA HIV observational cohort.
Clin Infect Dis. 2017 Nov 23. doi: 10.1093/cid/cix1004. [Epub ahead of print] Abstract

Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance
Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.
AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692. [Epub ahead of print] Abstract

CNS penetration of ART in HIV-infected children
Van den Hof M, Blokhuis C, Cohen S, Scherpbier HJ, Wit FWNM, Pistorius MCM, Kootstra NA, Teunissen CE, Mathot RAA, Pajkrt D.
J Antimicrob Chemother. 2017 Nov 8. doi: 10.1093/jac/dkx396. [Epub ahead of print] Abstract

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
Boyd MA, Mocroft A, Ryom L, Monforte AD, Sabin C, El-Sadr WM, Hatleberg CI, De Wit S, Weber R, Fontas E, Phillips A, Bonnet F, Reiss P, Lundgren J, Law M.
PLoS Med. 2017 Nov 7;14(11):e1002424. doi: 10.1371/journal.pmed.1002424. eCollection 2017 Nov. Abstract

Antiretroviral pill count and clinical outcomes in treatment naive patients with HIV
Young J, Smith C, Teira R, Reiss P, Jarrín Vera I, Crane H, Miro JM, D'Arminio Monforte A, Saag M, Zangerle R, Bucher HC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562. [Epub ahead of print] Abstract

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers
Van Zoest RA, Underwood J, De Francesco D, Sabin CA, Cole JH, Wit FW, Caan MWA, Kootstra NA, Fuchs D, Zetterberg H, Majoie CBLM, Portegies P, Winston A, Sharp DJ, Gisslén M1, Reiss P; Co-morBidity in Relation to AIDS (COBRA) Collaboration.
J Infect Dis. 2017 Oct 24. doi: 10.1093/infdis/jix553. [Epub ahead of print] Abstract

Cardiovascular disease prevention policy in human immunodeficiency virus: recommendations from a modeling study
Smit M, van Zoest RA, Nichols BE, Vaartjes I, Smit C, van der Valk M, van Sighem A, Wit FW, Hallett TB, and Reiss P; for The Netherlands AIDS Therapy Evaluation in The Netherlands (ATHENA) Observational HIV Cohort
Clinical Infectious Diseases, cix858, https://doi.org/10.1093/cid/cix858 Artikel

Brief report: High need to switch cART or comedication with the initiation of DAAs in elderly HIV/HCV-coinfected patients
Smolders EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM.
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):193-199. doi: 10.1097/QAI.0000000000001488. Abstract

Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus-infected middle-aged individuals compared with human immunodeficiency virus-uninfected controls
Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, Prins M, Post FA, Reiss P; AGEhIV Cohort Study.
 Infect Dis. 2017 Sep 15;216(6):622-631. doi: 10.1093/infdis/jix202. Abstract

CD4:CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus-infected patients on antiretroviral therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, Monforte AD, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola D, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
Clin Infect Dis. 2017 Sep 15;65(6):959-966. doi: 10.1093/cid/cix466. Abstract

Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls
Booiman T, Wit FW, Girigorie AF, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Franceschi 7, Deeks SG, Winston A, Reiss P, Kootstra NA; Co-morBidity in Relation to Aids (COBRA) Collaboration.
PLoS One. 2017 Aug 14;12(8):e0183357. doi: 10.1371/journal.pone.0183357. eCollection 2017. Abstract

Hypertension in people living with HIV
van Zoest RA, van den Born BH, Reiss P.
Curr Opin HIV AIDS. 2017 Aug 4. doi: 10.1097/COH.0000000000000406. [Epub ahead of print] Abstract

HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam
Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative.
BMC Infect Dis. 2017 Aug 1;17(1):529. doi: 10.1186/s12879-017-2617-0. Abstract

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
HIV Med. 2017 Jul 25. doi: 10.1111/hiv.12536. [Epub ahead of print] Abstract

Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older
Lodi S, Costagliola D, Sabin C, Amo JD, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill J, Krentz H, Phillips A, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.
J Acquir Immune Defic Syndr. 2017 Jul 21. doi: 10.1097/QAI.0000000000001498. [Epub ahead of print] Abstract

Towards standardised definitions for monitoring the continuum of HIV care in Europe
Gourlay AJ, Pharris AM, Noori T, Supervie V, Rosinska M, van Sighem A, Touloumi G, Porter K.
AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001597. [Epub ahead of print] Abstract

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study
Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, et al. on behalf of the COHERE in EuroCoord and ACHIeV2e Study Group
J Antimicrob Chemother. 2017. dkx210, https://doi.org/10.1093/jac/dkx210 Abstract

Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM
Vanhommerig JW, Bezemer D, Molenkamp R, Van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, Van Der Meer JT, Van De Laar TJ, Schinkel J; MOSAIC study and the ATHENA national observational cohort.
AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001592. [Epub ahead of print] Abstract

A survey of patients' perspectives on outpatient HIV care in the Netherlands
Engelhard EAN, Smit C, Kroon FP, Nieuwkerk PT, Reiss P, Brinkman K, Geerlings SE.
Infect Dis Ther. 2017 Jul 4. doi: 10.1007/s40121-017-0164-z. [Epub ahead of print] Abstract

High need to switch cART or co-medication with the initiation of DAAs in elderly HIV/HCV co-infected patients
Smolders EJ, Smit C, Tmm De Kanter C, Dofferhoff A, Arends JE, Brinkman K, Rijnders B, Van Der Valk M, Reiss P, Burger DM.
J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001488. [Epub ahead of print] Abstract

Mapping HIV prevalence in the Netherlands with geographic information systems [article in Dutch]
Op de Coul ELM, Joore IK, van Sighem A, Bom BCJ, Hillebregt M, Prins JM, Geerlings SE, van Bergen JEAM.
Ned Tijdschr Geneeskd. 2017;161(0):D965. Abstract

Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients.
van Bilsen WPH, van den Berg CHSB, Rijnders BJA, Brinkman K, Mulder JW, Gelinck LBS, Hoepelman AIM, Wit FWNM, van de Beek D, Prins JM.
AIDS. 2017 Jun 19;31(10):1415-1424. doi: 10.1097/QAD.0000000000001492. Abstract

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe
Blanquart F, Wymant C, Cornelissen M, Gall A, Bakker M, Bezemer D, Hall M, Hillebregt M, Ong SH, Albert J, Bannert N, Fellay J, Fransen K, Gourlay AJ, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Vanham G, Berkhout B, Kellam P, Reiss P, Fraser C; BEEHIVE collaboration.
PLoS Biol. 2017 Jun 12;15(6):e2001855. doi: 10.1371/journal.pbio.2001855. eCollection 2017 Jun. Abstract

The human immunodeficiency virus continuum of care in European Union countries in 2013: data and challenges 
Gourlay A, Noori T, Pharris A, Axelsson M, Costagliola D, Cowan S, Croxford S, d'Arminio Monforte A, Del Amo J, Delpech V, Díaz A, Girardi E, Gunsenheimer-Bartmeyer B, Hernando V, Jose S, Leierer G, Nikolopoulos G, Obel N, Op de Coul E, Paraskeva D, Reiss P, Sabin C, Sasse A, Schmid D, Sonnerborg A, Spina A, Suligoi B, Supervie V, Touloumi G, Van Beckhoven D, van Sighem A, Vourli G, Zangerle R, Porter K; European HIV Continuum of Care Working Group.
Clin Infect Dis. 2017 Jun 15;64(12):1644-1656. doi: 10.1093/cid/cix212 Abstract

Predictors of estimated glomerular filtration rate progression, stabilization or improvement afterchronic renal impairment in HIV-positive individuals.
Ryom L, Mocroft A, Kirk O, Reiss P, Ross M, Smith C, Moranne O, Morlat P, Fux CA, Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group.
AIDS. 2017 Jun 1;31(9):1261-1270. doi: 10.1097/QAD.0000000000001464. Abstract

Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Chêne G, Phillips A, Costagliola D, Sterne JA, Furrer H, Del Amo J, Mocroft A, d'Arminio Monforte A, Dabis F, Miro JM, Barger D, Termote M, Schwimmer C, Salbøl Brandt R, Friis-Moller N, Raben D, Haerry D, Egger M, Weller I, De Wit S.
Int J Epidemiol. 2017 Jun 1;46(3):797–797n. doi:10.1093/ije/dyw211 Abstract

Epidemiology of ageing with HIV: what can we learn from cohorts?
Sabin CA, Reiss P.
AIDS. 2017 Jun 1;31 Suppl 2:S121-S128. doi: 10.1097/QAD.0000000000001374. Abstract

High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid
Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA; Comorbidity in Relation to AIDS (COBRA) Collaboration.
Open Forum Infect Dis. 2017 May 25;4(3):ofx108. doi: 10.1093/ofid/ofx108. eCollection 2017 Summer. Abstract

Comparing viral load metrics and evaluating their use for HIV surveillance
Bolijn R, Op de Coul ELM, van Sighem A, Blok WL, Kretzschmar ME, Heijne JCM; ATHENA National Observational HIV Cohort.
J Infect. 2017 May 25. pii: S0163-4453(17)30144-5. doi: 10.1016/j.jinf.2017.05.010. [Epub ahead of print] Abstract

Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study
Bohlius J; AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord.
Clin Infect Dis. 2017 May 20. doi: 10.1093/cid/cix480. [Epub ahead of print] Abstract

Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort
Borges ÁH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo AL, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lungren JD, Mocroft A; for EuroSIDA.
Clin Infect Dis. 2017 May 15;64(10):1413-1421. doi: 10.1093/cid/cix167 Abstract

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
The Antiretroviral Therapy Cohort Collaboration
Lancet HIV 2017 Published Online May 10, 2017 http://dx.doi.org/10.1016/S2352-3018(17)30066-8 Artikel

20 jaar hiv-combinatietherapie in Nederland [20 years of HIV combination therapy in the Netherlands]
Brinkman K, Boender TS, van der Valk M, van Sighem A, Reiss P, Kroon FP
Ned Tijdschr Geneeskd. 2017;161: D1123 Artikel

Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals
Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT; AGEhIV Cohort Study Group.
AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511. [Epub ahead of print] Abstract

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study
Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration.; Centers for AIDS Research Network of Integrated Clinical Systems.
Lancet HIV. 2017 Apr 11. pii: S2352-3018(17)30043-7. doi: 10.1016/S2352-3018(17)30043-7. [Epub ahead of print] Abstract

Phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus–infected donors in the Netherlands and Flanders
van de Laar TJ, Bezemer D, van Laethem K, Vandewalle G, de Smet A, van Wijngaerden E, Claas EC, van Sighem AI, Vandamme AM, Compernolle V, Zaaijer HL.
Transfusion. 2017 Apr 4. doi: 10.1111/trf.14097. [Epub ahead of print] Abstract

Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function
Underwood J, Cole JH, Caan M, De Francesco D, Leech R, van Zoest RA, Su T, Geurtsen GJ, Schmand BA, Portegies P, Prins M, Wit FW, Sabin CA, Majoie C, Reiss P, Winston A, Sharp DJ; Co-morBidity in Relation to Aids (COBRA) Collaboration.
Clin Infect Dis. 2017 Apr 6. doi: 10.1093/cid/cix301. [Epub ahead of print] Abstract

Increased brain-predicted ageing in treated HIV disease
Cole JH, Underwood J, Caan MWA, De Francesco D, van Zoest RA, Leech R, Wit FWNM, Portegies P, Geurtsen GJ, Schmand B, Schim van der Loeff MF, Franceschi C, Sabin C, Majoie BLM, Winston A, Reiss P, Sharp DJ ; COBRA collaboration.
Neurology. 2017 Apr 4;88(14):1349-1357. doi: 10.1212/WNL.0000000000003790. Epub 2017 Mar 3. Abstract

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers
Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, Fidler S, Lehmann C, Zangerle R, Wittkop L, Reiss P, Hamouda O, Estrada Perez V, Leal M, Mocroft A, Garcia De Olalla P, Ammassari A, D'Arminio Monforte A, Mussini C, Segura F, Castagna A, Cavassini M, Grabar S, Morlat P, De Wit S, Lambotte O, Meyer L; HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD.
PLoS One. 2017 Apr 5;12(4):e0173893. doi: 10.1371/journal.pone.0173893. eCollection 2017. Abstract

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe
Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, Sawry S, Amorissani-Folquet M, Noguera-Julian A, Tanser F1, Eboua F, Navarro ML, Chimbetete C, Amani-Bosse C, Warszawski J, Phiri S, N'Gbeche S, Cox V, Koueta F, Giddy J, Sygnaté-Sy H, Raben D, Chêne G, Davies MA; IeDEA West and Southern Africa regional collaborations and COHERE in EuroCoord.
Int J Epidemiol. 2017 Apr 1;46(2):453-465. doi: 10.1093/ije/dyw097 Abstract

Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients?
Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2017 Mar 13;31(5):661-668. doi: 10.1097/QAD.0000000000001378. Abstract

Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children.
Blokhuis C, Mutsaerts HJ, Cohen S, Scherpbier HJ, Caan MW, Majoie CB, Kuijpers TW, Reiss P, Wit FW, Pajkrt D.
Medicine (Baltimore). 2017 Feb;96(7):e5891. doi: 10.1097/MD.0000000000005891. Abstract

Proactiever testen op hiv is nodig
Joore IK, Op de Coul ELM, Bom BCJ, van Sighem AI, Geerlings SE, Prins JM, van Bergen JEAM.
Huisarts Wet 2017;60(1):24-6. Abstract

An epidemiological modelling study to estimate the composition of HIV-positive populationsincluding migrants from endemic settings
Nakagawa F; Writing Group on HIV Epidemiologic Estimates in Countries With Migrant Populations From High Prevalence Areas.
AIDS. 2017 Jan 28;31(3):417-425. doi: 10.1097/QAD.0000000000001329. Abstract

Plasma HIV-1 tropism and the risk of short-term clinical progression to AIDS or death
Casadellà M,Cozzi-Lepri A, Phillips A, Noguera-Julian M, Bickel M,Sedlacek D, Zilmer K, Clotet B, Lundgren JD, Paredes R, on behalf of EuroSIDA in EuroCoord.
PLoS One. 2017 Jan 27;12(1):e0166613. doi: 10.1371/journal.pone.0166613. eCollection 2017. Abstract

Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy
Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study.
AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001414. [Epub ahead of print] Abstract

Timing of cART initiation in male and female migrants living with HIV in Western Europe: an observational cohort study (1997-2013)
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001411. [Epub ahead of print] Abstract

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women
van Snippenburg W, Nellen FJB, Smit C, Wensing AMJ, Godfried MH, Mudrikova T for the ATHENA cohort
Journal of Virus Eradication 2017; 3: 34–39 Artikel

Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe
Socio-economic Inequalities and HIV Working Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in Euro-Coord.
AIDS. 2017 Jan 14;31(2):253-262. doi: 10.1097/QAD.0000000000001270. Abstract

Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy
van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P; AGEhIV Cohort Study Group.
Eur J Prev Cardiol. 2017 Jan 1:2047487317714350. doi: 10.1177/2047487317714350. [Epub ahead of print] Abstract

 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.

Bezoekadres

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam

Postadres

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon